{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:51:23Z","timestamp":1792633883662,"version":"4.5.0"},"reference-count":31,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"IFORES research","award":["RA 969\/12-1"],"award-info":[{"award-number":["RA 969\/12-1"]}]},{"name":"University Duisburg-Essen, Hufelandstra\u00dfe 55, 45147 Essen, Germany (LM)","award":["RA 969\/12-1"],"award-info":[{"award-number":["RA 969\/12-1"]}]},{"name":"Deutsche Forschungsgemeinschaft","award":["RA 969\/12-1"],"award-info":[{"award-number":["RA 969\/12-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The programmed cell death protein 1 (PD1) immune checkpoint prevents inflammatory tissue damage by inhibiting immune reactions. Understanding the relevance of cardiac PD1 signaling may provide new insights into the inflammatory events under baseline conditions and disease. Here, we demonstrate distinct immunological changes upon PD1 deficiency in healthy hearts and during reperfused acute myocardial infarction (repAMI). In PD1-deficient mice, upregulated inflammatory cytokines were identified under baseline conditions including cardiac interleukins and extracellular signal-related kinase 1\/2 (ERK1\/2). A murine in vivo repAMI model to determine inflammatory changes in the early phase showed downregulation of the ligand PDL1, paralleled by an endothelial injury, indicated by loss of the CD31 signal. Immunofluorescence imaging showed decreased PDL1 expression specifically in the infarct zone, highlighting an involvement in PDL1 in myocardial injury response. Pharmacological depletion of PD1 prior to repAMI did not alter the area of infarction but led to increased numbers of CD8+ T cells in treated mice. We conclude that PD1\/PDL1 signaling plays a significant role in healthy hearts and repAMI, emphasizing the relevance of adaptive immunity during myocardial injury. The findings highlight the risk for adverse outcomes from acute myocardial infarction in the growing group of patients receiving immune checkpoint inhibitor therapy.<\/jats:p>","DOI":"10.3390\/ijms23147533","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T07:51:56Z","timestamp":1657180316000},"page":"7533","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial Infarction"],"prefix":"10.3390","volume":"23","author":[{"given":"Lars","family":"Michel","sequence":"first","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstra\u00dfe 55, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Korste","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstra\u00dfe 55, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Spomer","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstra\u00dfe 55, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike Barbara","family":"Hendgen-Cotta","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstra\u00dfe 55, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8001-0265","authenticated-orcid":false,"given":"Tienush","family":"Rassaf","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstra\u00dfe 55, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Totzeck","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstra\u00dfe 55, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"ref_1","unstructured":"(2022, January 18). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: A neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/cvr\/cvz025","article-title":"T cell checkpoint regulators in the heart","volume":"115","author":"Grabie","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: From T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S1470-2045(18)30457-1","article-title":"Immune checkpoint inhibitors and cardiovascular toxicity","volume":"19","author":"Lyon","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_8","first-page":"100420","article-title":"Cardiotoxicity from immune checkpoint inhibitors","volume":"25","author":"Michel","year":"2019","journal-title":"IJC Hear. Vasc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00392-020-01636-7","article-title":"Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology","volume":"109","author":"Rassaf","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant Myocarditis with Combination Immune Checkpoint Blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/eurheartj\/ehab430","article-title":"Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy","volume":"43","author":"Michel","year":"2021","journal-title":"Eur. Hear. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/CIRCULATIONAHA.107.709360","article-title":"Endothelial Programmed Death-1 Ligand 1 (PD-L1) Regulates CD8 + T-Cell\u2013Mediated Injury in the Heart","volume":"116","author":"Grabie","year":"2007","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Baban, B., Liu, J.Y., Qin, X., Weintraub, N., and Mozaffari, M.S. (2015). Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124059"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-021-00903-6","article-title":"Cardiac dysfunction from cancer and cancer therapy: New pathways for the prevention of late cardiotoxicity","volume":"116","author":"Michel","year":"2021","journal-title":"Basic Res. Cardiol."},{"key":"ref_15","first-page":"3940","article-title":"Immune checkpoint proteins: Exploring their therapeutic potential to regulate atherosclerosis","volume":"174","author":"Foks","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/ATVBAHA.111.224709","article-title":"Impairment of the Programmed Cell Death-1 Pathway Increases Atherosclerotic Lesion Development and Inflammation","volume":"31","author":"Bu","year":"2011","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/eurheartj\/ehaa959","article-title":"Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?","volume":"42","author":"Totzeck","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_19","first-page":"1621","article-title":"The risk of cardiac events in patients receiving immune checkpoint inhibitors: A nationwide Danish study","volume":"42","author":"Nielsen","year":"2020","journal-title":"Eur. Hear. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41419-020-02778-2","article-title":"Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a\/Kruppel-like factor 4 signaling","volume":"11","author":"Xia","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/eurheartj\/ehab584","article-title":"Novel actors on the stage of cardiac dysfunction induced by anti-PD1 oncological treatments","volume":"43","author":"Varricchi","year":"2021","journal-title":"Eur. Hear. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jtho.2017.12.002","article-title":"PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes","volume":"13","author":"Du","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF02126586","article-title":"Relationship between interleukin 1 (IL1), tumor necrosis factor (TNF) and a neutrophil attracting peptide (NAP-1)","volume":"26","author":"Oppenheim","year":"1989","journal-title":"Agents Actions"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1073\/pnas.88.10.4220","article-title":"Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1","volume":"88","author":"Walsh","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1947601911407328","article-title":"The ERK Cascade: Distinct Functions within Various Subcellular Organelles","volume":"2","author":"Wortzel","year":"2011","journal-title":"Genes Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"21695","DOI":"10.1074\/jbc.M701419200","article-title":"Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-alpha (TNF-alpha) expression via ERK1\/2 activation and Egr-1 expression: Role of TNF-alpha in adiponectin-stimulated interleukin-10 production","volume":"282","author":"Park","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/cvr\/cvx248","article-title":"Exploring immune checkpoints as potential therapeutic targets in atherosclerosis","volume":"114","author":"Kusters","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jaccao.2020.08.007","article-title":"Immune Checkpoint Inhibitor Therapy Aggravates T Cell\u2013Driven Plaque Inflammation in Atherosclerosis","volume":"2","author":"Poels","year":"2020","journal-title":"JACC CardioOncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.4049\/jimmunol.179.8.5064","article-title":"PD-1 Regulates Self-Reactive CD8+ T Cell Responses to Antigen in Lymph Nodes and Tissues","volume":"179","author":"Keir","year":"2007","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.14440\/jbm.2016.149","article-title":"A practical approach to remote ischemic preconditioning and ischemic preconditioning against myocardial ischemia\/reperfusion injury","volume":"3","author":"Totzeck","year":"2016","journal-title":"J. Biol. Methods"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/s41467-019-10338-2","article-title":"Contemporaneous 3D characterization of acute and chronic myocardial I\/R injury and response","volume":"10","author":"Merz","year":"2019","journal-title":"Nat. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/14\/7533\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:43:57Z","timestamp":1760139837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/14\/7533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":31,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["ijms23147533"],"URL":"https:\/\/doi.org\/10.3390\/ijms23147533","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]}}}